Exicure, Inc. (XCUR)
NASDAQ: XCUR · Real-Time Price · USD
3.470
-0.090 (-2.53%)
At close: Apr 28, 2026, 4:00 PM EDT
3.190
-0.280 (-8.07%)
Pre-market: Apr 29, 2026, 4:05 AM EDT
Exicure Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for Exicure.
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for Exicure.
Recommendation Trends
| Rating | Mar '22 | Apr '22 | May '22 | Jun '22 | Jul '22 | Aug '22 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 0 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Chardan Capital | Chardan Capital | Hold Maintains $1.25 → $10 | Hold | Maintains | $1.25 → $10 | +188.18% | Aug 16, 2022 |
| Chardan Capital | Chardan Capital | Strong Buy → Hold Downgrades $338 → $60 | Strong Buy → Hold | Downgrades | $338 → $60 | +1,629.11% | Dec 13, 2021 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $1,050 → $338 | Strong Buy | Maintains | $1,050 → $338 | +9,626.22% | Nov 23, 2021 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $1,200 → $900 | Strong Buy | Maintains | $1,200 → $900 | +25,836.60% | May 17, 2021 |
| BMO Capital | BMO Capital | Buy Initiates $900 | Buy | Initiates | $900 | +25,836.60% | Dec 18, 2020 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
n/a
from -0.79
EPS Next Year
n/a
Revenue Forecast
| Revenue |
|---|
| High |
| Avg |
| Low |
Revenue Growth
| Revenue Growth |
|---|
| High |
| Avg |
| Low |
EPS Forecast
| EPS |
|---|
| High |
| Avg |
| Low |
EPS Growth
| EPS Growth |
|---|
| High |
| Avg |
| Low |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.